These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10722271)

  • 21. Thalidomide in severe orogenital ulceration.
    Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
    Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions.
    Moffatt RJ; Biggerstaff KD; Stamford BA
    Prev Med; 2000 Aug; 31(2 Pt 1):148-52. PubMed ID: 10938215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial.
    Simon JA; Carmody TP; Hudes ES; Snyder E; Murray J
    Am J Med; 2003 May; 114(7):555-62. PubMed ID: 12753879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.
    McClernon FJ; Hiott FB; Westman EC; Rose JE; Levin ED
    Psychopharmacology (Berl); 2006 Nov; 189(1):125-33. PubMed ID: 16977477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferences among four combination nicotine treatments.
    Schneider NG; Koury MA; Cortner C; Olmstead RE; Hartman N; Kleinman L; Kim A; Chaya C; Leaf D
    Psychopharmacology (Berl); 2006 Sep; 187(4):476-85. PubMed ID: 16896965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
    Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight change after smoking cessation using variable doses of transdermal nicotine replacement.
    Dale LC; Schroeder DR; Wolter TD; Croghan IT; Hurt RD; Offord KP
    J Gen Intern Med; 1998 Jan; 13(1):9-15. PubMed ID: 9462489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking cessation. Part 2: Nicotine replacement therapy.
    Thomas S
    Nurs Stand; 2007 Oct 10-16; 22(5):44-7. PubMed ID: 17977138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Hotline. Oral allicin in the treatment of Behcet's disease through attenuating oxidative stress: A pilot study in 20 patients with mucocutaneous lesions.
    Zhong J; Xian D; Xiong X; Liu J
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medications to Assist in Tobacco Cessation for Dental Patients.
    Levy JM; Abramowicz S
    Dent Clin North Am; 2016 Apr; 60(2):533-40. PubMed ID: 27040301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genital ulceration].
    Verraes-Derancourt S; Derancourt Ch; Janier M; Dupin N; Gerhardt P; Alcaraz I;
    Ann Dermatol Venereol; 2006; 133(8-9 Pt 2):2S51-2S52. PubMed ID: 17072178
    [No Abstract]   [Full Text] [Related]  

  • 34. Nicotine therapy for ulcerative colitis.
    Kennedy LD
    Ann Pharmacother; 1996 Sep; 30(9):1022-3. PubMed ID: 8876866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral and genital lichenoid reactions associated with circulating autoantibodies to desmoplakins I and II: a novel target antigen or example of epitope spreading?
    Oyama N; Setterfield JF; Gratian MJ; Bhogal BS; Shirlaw P; Challacombe SJ; Black MM
    J Am Acad Dermatol; 2003 Mar; 48(3):433-8. PubMed ID: 12637926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic effect of cigarette smoking on oral/genital aphthosis and other manifestations of Behçet's disease.
    Rizvi SW; McGrath H
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S77-8. PubMed ID: 11760408
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
    Morissette SB; Palfai TP; Gulliver SB; Spiegel DA; Barlow DH
    Psychol Addict Behav; 2005 Jun; 19(2):192-8. PubMed ID: 16011390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide, orogenital ulcers, and the risk of teratogenesis.
    Lehner T; Sullivan FM
    Lancet; 1985 Feb; 1(8423):288-9. PubMed ID: 2857357
    [No Abstract]   [Full Text] [Related]  

  • 39. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
    Kalman D; Kahler CW; Garvey AJ; Monti PM
    J Subst Abuse Treat; 2006 Apr; 30(3):213-7. PubMed ID: 16616165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.